The results indicated that tumor size, lymph node metastasis, pTNM stage, cIAP1 expression, and cIAP1+/ cIAP2+ were good predictors of OS for NSCLC patients (Table 4). Here, BIRC3 is linked to metastatic malignant neoplasm in the lymph nodes.